J. Watkin

发表

Type I error rates from likelihood‐based repeated measures analyses of incomplete longitudinal data

R. Carroll, G. Molenberghs, M. Detke, 2004 .

Duloxetine in the treatment of major depressive disorder: an open-label study

M. Detke, J. Hudson, J. Watkin, 2007, BMC psychiatry.

Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.

D. Stewart, S. Kornstein, C. Mallinckrodt, 2006, Journal of affective disorders.

Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

M. Fava, P. Delgado, J. Greist, 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.

M. Detke, S. Brannan, G. Tollefson, 2005, Journal of psychiatric research.

An Open-label Study of Duloxetine for the Treatment of Major Depressive Disorder: Comparison of Switching Versus Initiating Treatment Approaches

M. Fava, C. Mallinckrodt, J. Martinez, 2005, Journal of clinical psychopharmacology.

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

C. Mallinckrodt, J. Watkin, M. Wohlreich, 2004, BMC geriatrics.

The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

M. Detke, C. Mallinckrodt, J. Raskin, 2004, BMC psychiatry.

Duloxetine's role in the treatment of depression and associated painful physical symptoms.

J. Watkin, M. Wohlreich, J. Gonzales, 2004, The Journal of clinical psychiatry.

The Role of Duloxetine in the Treatment of Depression and Associated Painful Physical Symptoms.

J. Watkin, M. Wohlreich, 2003, Primary care companion to the Journal of clinical psychiatry.

Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.

B. Mccarberg, Y. Pritchett, M. Robinson, 2006, Pain medicine.

Dissolution of Lanthanide and Actinide Metals Using Iodine and 2-Propanol. Synthesis and x-ray Crystal Structures of LnI3(HO-i-Pr)4 (Ln = La, Ce) and Th2I4(O-i-Pr)4(HO-i-Pr)2

N. Sauer, J. Watkin, D. Barnhart, 1995 .

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

M. Demitrack, C. Mallinckrodt, Yili Lu, 2002, The Journal of clinical psychiatry.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

D. Stewart, S. Kornstein, C. Mallinckrodt, 2006, The Journal of clinical psychiatry.

Plutonium(III)-catalyzed Meerwein–Ponndorf–Verley reactions

C. Burns, A. Schake, B. Warner, 2000 .

Highly electrophilic lanthanide complexes containing fluorinated amido ligands: multiple Ln···F interactions, agostic interactions and η6-arene coordination

B. Scott, J. Watkin, D. Click, 1999 .

Synthesis and characterization of a mixed-ring bis-cyclopentadienyl derivative of neodymium. X-ray crystal structures of (η-C5Me5)NdI2(py)3 and (η-C5Me5)(η-C5H4SiMe3)NdI(py)

B. Scott, D. L. Clark, J. Gordon, 1999 .

AN UNPRECEDENTED CYCLIC STRUCTURE FOR A MONOCYCLOPENTADIENYL METAL COMPLEX: PREPARATION AND X-RAY CRYSTAL STRUCTURE OF (ETA -C5H5)TH2(O-I-PR)73

R. Butcher, D. L. Clark, J. Gordon, 1995 .

PREPARATION OF MONO-PENTAMETHYLCYCLOPENTADIENYL URANIUM(IV) SULFIDO CLUSTERS THROUGH OXIDATION OF (ETA -C5ME5)UL2(THF)3. X-RAY STRUCTURAL CHARACTERIZA TION OF (ETA -C5ME5)3U3(MU 3-I)(MU 3-S)(MU 2-I)3I3

J. Huffman, D. L. Clark, J. Gordon, 1995 .

Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years.

D. Stewart, M. Detke, V. Burt, 2005, Psychosomatics.

Tris(bis(trimethylsilyl)amido)samarium: X-ray structure and DFT study.

B. Scott, P. Hay, E. Brady, 2003, Inorganic chemistry.

Synthesis and characterization of thorium tert-butoxide complexes: x-ray crystal structures of Th(O-tert-Bu)4(py)2 and NaTh2(O-tert-Bu)9

D. L. Clark, J. Watkin, 1993 .

Crystal structure of the zerovalent niobium complex Nb (η-C6H5Me)2

D. L. Clark, J. Gordon, J. Watkin, 1996 .

Neutral and anionic transition metal complexes supported by decafluorodiphenylamido ligands: X-ray crystal structures of {Na(THF)2}{Ti[N(C6F5)2]4}, {K(η6-C6H5Me)2}{ZrCl2[N(C6F5)2]3}, K{VCl[N(C6F5)2]3}, Fe[N(C6F5)2]2(THF)2 and Co[N(C6F5)2]2(py)2

B. Scott, D. L. Clark, J. Gordon, 2003 .

Metal complexes based on an upper-rim calix[4]arene phosphine ligand

B. Scott, G. Kubas, Xinggao Fang, 2001 .

Ytterbium Trichloride-Catalyzed Diels-Alder Reactions of Unactivated Dienes

Xinggao Fang, B. Warner, J. Watkin, 2000 .

The first structurally characterised homoleptic thorium alkoxide: X-ray crystal structure of [Th(OCHPri2)4]2, and NMR evidence for a monomer–dimer equilibrium

J. Huffman, D. L. Clark, J. Watkin, 1992 .

STRUCTURAL CHARACTERIZATION AND REACTIVITY STUDIES OF THE SAMARIUM ARYLOXIDE COMPLEX SM(O-2,6-PR2IC6H3)3(THF)2

J. Huffman, D. L. Clark, J. Gordon, 1996 .

Electrophilic Cationic Palladium(II) Complexes Containing a Diimine Ligand with Pendant Thienyl Groups. X-ray Structure of {PdIIMe[1,4-bis(2‘-(2- thienyl)ethyl)2,3-dimethyl-1,4-diazabutadiene]}+

G. Kubas, Xinggao Fang, J. Watkin, 2001 .

Ytterbium trichloride-catalyzed allylation of aldehydes with allyltrimethylsilane

Xinggao Fang, B. Warner, J. Watkin, 2000 .

Mono(pentamethylcyclopentadienyl)thorium Chemistry: Synthesis, Structural Characterization, and Reactivity of Aryloxide and Alkyl Derivatives

B. Scott, R. Butcher, D. L. Clark, 1996 .

Sterically demanding aryloxides as supporting ligands in organoactinide chemistry. Synthesis, structural characterization, and reactivity of Th(O-2,6-t-Bu{sub 2}C{sub 6}H{sub 3}){sub 2}(CH{sub 2}SiMe{sub 3}){sub 2} and formation of the trimeric thorium hydride Th{sub 3}H{sub 6}(O-2,6-t-Bu{sub 2}C{su

B. Scott, D. L. Clark, J. Watkin, 1996 .

Observation of a Significantly Reduced 1JC-H Coupling Constant in an Agostic f-Element Complex: X-ray Crystal Structure of (ArO)Sm[(μ-OAr)(μ-Me)AlMe2]2 (Ar = 2,6-i-Pr2C6H3)

B. Scott, D. L. Clark, D. Keogh, 2002 .

Samarium alkyl-aryloxide complex containing a trigonal bipyramidal carbon atom. X-ray structure of [Li(THF)][sub 2][Sm(O-2,6-i-Pr[sub 2]C[sub 6]H[sub 3])[sub 3] CH[sub 2]SiMe[sub 3][sub 2]]

J. Huffman, D. L. Clark, J. Gordon, 1994 .

Interactions of Remote Alkyl Groups with Lanthanide Metal Centers: Synthesis, Characterization and Ligand Redistribution Reactions of Heterobimetallic Species Containing Trialkylaluminum Fragments

B. Scott, R. Michalczyk, D. L. Clark, 2002 .

Synthesis and structural characterization of the lanthanide Schiff-base complexes {N[CH2CH2NCH(2-O-3,5-t-Bu2C6H2)]3}Ln (Ln=Sm, Nd)

B. Scott, D. Keogh, J. Watkin, 2001 .

Synthesis and Structure of a Diphosphonite-Bridged Ruthenium Dication, {[(p-cymene)Ru(μ-Cl)]2(μ-1,2-di(2‘2‘-diethyl-1‘,3‘-propanedioxy)phosphinoethane)}2+

B. Scott, G. Kubas, K. John, 2003 .

Ammoniacal Synthesis of Lanthanum Aryloxide Complexes and Observation of a Unique Interconversion between Oxygen- and .eta.-Arene-Bridged Dimeric Species. X-ray Crystal Structures of La2(OAr)6(NH3)n (n = 0, 2), La(OAr)3(NH3)4, and La(OAr)3(THF)2 (Ar = 2,6-i-Pr2C6H3)

B. Scott, R. Butcher, D. L. Clark, 1995 .

A mechanistic study of the samarium(II)-mediated reduction of aryl nitro compounds to the corresponding crylamines. The crystal structures of [Sm[N(SiMe(3))(2)](2)(thf)](2)(mu(2)-O) and [(Me(3)Si)(2)N](2)Sm(thf)(mu-PhNNPh)Sm[N(SiMe(3))(2)](2).

B. Scott, E. Brady, D. L. Clark, 2002, Journal of the American Chemical Society.

A convenient entry into trivalent actinide chemistry : synthesis and characterization of AnI3(THF)4 and an[N(SiMe3)2]3 (an = U, Np, Pu)

S. Bott, D. L. Clark, L. Avens, 1994 .

Synthesis and X-ray crystal structures of the samarium mono(pentamethylcyclopentadienyl) aryloxide complexes (η-C5Me5)Sm(O-2,6-t-Bu2C6H3)2(THF) and [(η-C5Me5)Sm(O-2,6-i-Pr2C6H3)3Li(THF)]. Differences in metathesis chemistry of 2,6-di-iso-propylphenoxide and 2,6-di-tert-butylphenoxide ligands

R. Butcher, D. L. Clark, J. Gordon, 1999 .

Alkali Metal Induced Structural Changes in Complexes Containing Anionic Lanthanum Aryloxide Moieties. X-ray Crystal Structures of (THF)La(OAr)2(μ-OAr)2Li(THF), (THF)La(OAr)2(μ-OAr)2Na(THF)2, and CsLa(OAr)4 (Ar = 2,6-i-Pr2C6H3)

B. Scott, D. L. Clark, J. Watkin, 1996 .

First single-crystal X-ray diffraction study of a lanthanide tricarbonate complex: [Co(NH3)6][Sm(CO3)3(H2O)]·4H2O

B. Scott, D. L. Clark, D. Keogh, 2000 .

New homoleptic anionic aryloxolanthanide(III) complexes with unusual coordination trapping of the alkali-metal counter ions

B. Scott, G. Deacon, B. Skelton, 1996 .

Preparation and X-ray Structures of K[Ln(O-2,6-i-Pr2C6H3)4] (Ln = La, Nd, Er). Extended Chain Structures of Lanthanide Tetrakis(Aryloxide) Anions Bridged by Potassium-.eta.-Arene Interactions

J. Huffman, D. L. Clark, J. Gordon, 1994 .

Synthesis, Properties, and X-ray Structures of the Lanthanide .eta.6-Arene-Bridged Aryloxide Dimers Ln2(O-2,6-i-Pr2C6H3)6 and Their Lewis Base Adducts Ln(O-2,6-i-Pr2C6H3)3(THF)2 (Ln = Pr, Nd, Sm, Gd, Er, Yb, Lu)

J. Huffman, D. L. Clark, J. Gordon, 1994 .

Early actinide alkoxide chemistry. Synthesis, characterization, and molecular structures of Th(IV) and U(IV) aryloxide complexes

J. Huffman, D. L. Clark, W. E. Streib, 1992 .

New developments in actinide alkoxide chemistry

D. L. Clark, A. Sattelberger, J. Watkin, 1992 .

Synthesis, structure and reactivity of new low-valent mono(η-arene)niobium compounds

Malcolm L. H. Green, D. O′Hare, P. Mountford, 1991 .

Preparation and x-ray crystal structure of potassium tetrakis(2,6-diisopropoxyphenolato)neodymate(1-): a one-dimensional chain of lanthanide aryloxide anions joined by bis(.eta.6-arene)-potassium interactions

J. Huffman, D. L. Clark, J. Watkin, 1992 .

Solution study of the ambient temperature monomer-dimer equilibrium Th{sub 2}(OR){sub 8}{rightleftharpoons} 2Th(OR){sub 4} (R = CH-i-Pr{sub 2}) and X-ray crystal structures of Th{sub 2}(OCH-i-Pr{sub 2}){sub 8}, Th(OCH-i-Pr{sub 2}){sub 4}(quin), and ThI(OCH-i-Pr{sub 2}){sub 3}(py){sub 2}

J. Huffman, D. L. Clark, J. Gordon, 1995 .

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

A. Schatzberg, S. Brannan, C. Mallinckrodt, 2005, Journal of psychiatric research.

Mono(pentamethylcyclopentadienyl)thorium Chemistry. Formation and Structural Characterization of a Novel Triflate-Bridged Dimeric Thorium Complex

R. Butcher, D. L. Clark, J. Watkin, 1995 .

Synthesis of Neutral and Anionic Uranyl Aryloxide Complexes from Uranyl Amide Precursors: X-ray Crystal Structures of UO2(O-2,6-i-Pr2C6H3)2(py)3 and [Na(THF)3]2[UO2(O-2,6-Me2C6H3)4]

C. Burns, N. Sauer, J. Watkin, 1995 .

Mono(pentamethylcyclopentadienyl)uranium(III) Complexes: Synthesis, Properties, and X-ray Structures of (η-C5Me5)UI2(THF)3, (η-C5Me5)UI2(py)3, and (η-C5Me5)U[N(SiMe3)2]2

B. Scott, R. Butcher, C. Burns, 2000 .

Facile solution routes to hydrocarbon-soluble Lewis base adducts of thorium tetrahalides. Synthesis, characterization, and x-ray structure of ThBr4(THF)4

D. L. Clark, J. Watkin, Tracey M. Frankcom, 1992 .

Synthesis, characterization, and x-ray structure of the uranium thiolate complex U(S-2,6-Me2C6H3)[N(SiMe3)2]3

D. L. Clark, J. Watkin, M. Miller, 1993 .

Synthesis of Thorium Amide Complexes via Halide Metathesis and Transamination Procedures: X-ray Structure of Th[N(SiMe3)2]2(NMePh)2

D. L. Clark, J. Watkin, D. Barnhart, 1995 .

Oligomerization of Metal-Oxygen Bonds in Thorium Alkoxide Chemistry: X-ray Crystal Structures of Th4(O-i-Pr)16(py)2 and Th2(OCHEt2)8(py)2

J. Huffman, D. L. Clark, J. Gordon, 1994 .

Formation of a samarium alkoxide–aryloxide complex containing a novel butterfly framework: X-ray crystal structures of Sm4(μ3-O-i-Pr)3(μ2-O-i-Pr)4(O-i-Pr)2(O-2,6-i-Pr2C6H3)3(THF) and [Ti(O-i-Pr)2(O-2,6-i-Pr2C6H3) (μ-O-i-Pr)]2

B. Scott, J. Watkin, D. Click, 1999 .

Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

C. Mallinckrodt, J. Watkin, A. Andorn, 2006, Journal of psychiatric research.

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.

J. Calabrese, M. Tohen, H. Akiskal, 2004, The British journal of psychiatry : the journal of mental science.

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo‐controlled clinical trials

D. Kajdasz, C. Mallinckrodt, J. Hudson, 2005, Human psychopharmacology.

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features

C. Mallinckrodt, Chaofeng Liu, J. Raskin, 2005, BMC psychiatry.

Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis.

C. Mallinckrodt, J. Raskin, M. Sullivan, 2009, Psychosomatics.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Craig H Mallinckrodt, Maurizio Fava, M. Fava, 2004, The Journal of clinical psychiatry.

Choice of the primary analysis in longitudinal clinical trials

Geert Molenberghs, Raymond J. Carroll, Craig H. Mallinckrodt, 2004 .

Synthesis and energetic content of red oil

John G. Watkin, Pamela L. Gordon, Charles O'Dell, 1994 .

Investigation of red oil decomposition by simulated Hanford tank wastes

J. Watkin, P. Gordon, C. O'dell, 1994 .

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

M. Detke, P. Delgado, S. Brannan, 2005, The Journal of clinical psychiatry.

Duloxetine for the treatment of major depressive disorder in older patients.

M. Detke, J. Nelson, C. Mallinckrodt, 2005, The American journal of geriatric psychiatry.

Tetrameric lanthanide neopentoxide complexes with agostic Ln-H-C interactions. X-ray crystal structures of Ln[sub 4](OCH[sub 2]-t-Bu)[sub 12] (Ln = La, Nd)

J. Huffman, D. L. Clark, J. Gordon, 1993 .

Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects

E. Lainey, F. Vandenhende, L. Staner, 2005, Psychopharmacology.

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression

R. Shelton, M. Detke, C. Mallinckrodt, 2007, International clinical psychopharmacology.

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression.

M. Detke, C. Mallinckrodt, Yili Lu, 2003, Primary care companion to the Journal of clinical psychiatry.

The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA

Geert Molenberghs, Craig H Mallinckrodt, Raymond J Carroll, 2004, Clinical trials.

Triphenylmethyl tris(p-methoxyphenyl)phosphonium cation: a structurally characterized phosphonium analog of hexaphenylethane

B. Scott, G. Kubas, K. John, 2000 .

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

C. Mallinckrodt, J. Watkin, W. P. Carter, 2007, Depression and anxiety.

Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting doses.

M. Fava, D. Dunner, C. Mallinckrodt, 2005, Current therapeutic research, clinical and experimental.

Unique molecular structure of the actinide hydrido aryloxide complex Th{sub 3}({mu}{sub 3}-H){sub 2}({mu}{sub 2}-JH){sub 4}(O-2,6-t-Bu{sub 2}C{sub 6}H{sub 3}){sub 6}

B. Scott, D. L. Clark, J. Watkin, 1995 .

Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patients.

C. Blanco, C. Mallinckrodt, J. Watkin, 2006, The Journal of clinical psychiatry.

Comparing onset of antidepressant action using a repeated measures approach and a traditional assessment schedule

R. Carroll, G. Molenberghs, M. Detke, 2006, Statistics in medicine.